Yale HTC — New Haven, Connecticut

Yale HTC is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Yale HTC has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Hemophilia B.

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale HTC?

Yale HTC has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale HTC conducted?

Yale HTC has 2 clinical trials on record, with 2 currently active. Their work covers Hemophilia B.

Is Yale HTC accredited by Crixeo Health?

Yale HTC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale HTC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.